BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25435270)

  • 1. PET-CT offers accurate assessment of tumour length in oesophageal malignancy.
    Rollins KE; Lucas E; Tewari N; James E; Hughes S; Catton JA
    Eur J Radiol; 2015 Feb; 84(2):195-200. PubMed ID: 25435270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma.
    Salahudeen HM; Balan A; Naik K; Mirsadraee S; Scarsbrook AF
    Clin Radiol; 2008 Jul; 63(7):765-73. PubMed ID: 18555034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-staging of oesophageal and junctional carcinoma: is there still a role for EUS in patients staged N0 at PET/CT?
    Foley KG; Lewis WG; Fielding P; Karran A; Chan D; Blake P; Roberts SA
    Clin Radiol; 2014 Sep; 69(9):959-64. PubMed ID: 24916652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of 18-FDG PET/CT and EUS-defined tumour characteristics in patients with oesophageal cancer.
    Chan DS; Fielding P; Roberts SA; Reid TD; Ellis-Owen R; Lewis WG
    Clin Radiol; 2013 Apr; 68(4):352-7. PubMed ID: 22981727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiological prediction of positive circumferential resection margin in oesophageal cancer.
    Foley KG; Christian A; Patel N; Lewis WG; Roberts SA
    Eur J Radiol; 2018 Oct; 107():119-124. PubMed ID: 30292255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective comparison of MR with diffusion-weighted imaging, endoscopic ultrasound, MDCT and positron emission tomography-CT in the pre-operative staging of oesophageal cancer: results from a pilot study.
    Giganti F; Ambrosi A; Petrone MC; Canevari C; Chiari D; Salerno A; Arcidiacono PG; Nicoletti R; Albarello L; Mazza E; Gallivanone F; Gianolli L; Orsenigo E; Esposito A; Staudacher C; Del Maschio A; De Cobelli F
    Br J Radiol; 2016 Dec; 89(1068):20160087. PubMed ID: 27767330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of quantitative assessment with fluorine-18-fluorodeoxyglucose positron-emission tomography and endoscopic ultrasound in oesophageal cancer.
    Borakati A; Razack A; Cawthorne C; Roy R; Usmani S; Ahmed N
    Nucl Med Commun; 2018 Jul; 39(7):628-635. PubMed ID: 29672466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma.
    Konski A; Doss M; Milestone B; Haluszka O; Hanlon A; Freedman G; Adler L
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1123-8. PubMed ID: 15752892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour delineation in oesophageal cancer - A prospective study of delineation in PET and CT with and without endoscopically placed clip markers.
    Thomas L; Lapa C; Bundschuh RA; Polat B; Sonke JJ; Guckenberger M
    Radiother Oncol; 2015 Aug; 116(2):269-75. PubMed ID: 26364886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.
    Katsoulis IE; Wong WL; Mattheou AK; Damani N; Chambers J; Livingstone JI
    Int J Surg; 2007 Dec; 5(6):399-403. PubMed ID: 17631431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
    Swisher SG; Maish M; Erasmus JJ; Correa AM; Ajani JA; Bresalier R; Komaki R; Macapinlac H; Munden RF; Putnam JB; Rice D; Smythe WR; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
    Ann Thorac Surg; 2004 Oct; 78(4):1152-60; discussion 1152-60. PubMed ID: 15464463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
    Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma.
    Yen TJ; Chung CS; Wu YW; Yen RF; Cheng MF; Lee JM; Hsu CH; Chang YL; Wang HP
    Dis Esophagus; 2012 Jan; 25(1):40-7. PubMed ID: 21595776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Positron Emission Tomography and Endoscopic Ultrasound Length of Disease Difference on Treatment Planning in Patients with Oesophageal Cancer.
    Foley KG; Morgan C; Roberts SA; Crosby T
    Clin Oncol (R Coll Radiol); 2017 Nov; 29(11):760-766. PubMed ID: 28818538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is positron emission tomography useful in locoregional staging of esophageal cancer? Results of a multidisciplinary initiative comparing CT, positron emission tomography, and EUS.
    Sandha GS; Severin D; Postema E; McEwan A; Stewart K
    Gastrointest Endosc; 2008 Mar; 67(3):402-9. PubMed ID: 18178202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of integrated PET/CT in the staging of oesophageal cancer: a UK population-based cohort study.
    Noble F; Bailey D; ; Tung K; Byrne JP
    Clin Radiol; 2009 Jul; 64(7):699-705. PubMed ID: 19520214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does pre-operative estimation of oesophageal tumour metabolic length using 18F-fluorodeoxyglucose PET/CT images compare with surgical pathology length?
    Jeganathan R; McGuigan J; Campbell F; Lynch T
    Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):656-62. PubMed ID: 21161213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-operative staging of gastro-oesophageal junction carcinoma: comparison of endoscopic ultrasound and computed tomography.
    Holden A; Mendelson R; Edmunds S
    Australas Radiol; 1996 Aug; 40(3):206-12. PubMed ID: 8826718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of novel ¹⁸F-FDG PET/CT defined tumour variables in patients with oesophageal cancer.
    Foley KG; Fielding P; Lewis WG; Karran A; Chan D; Blake P; Roberts SA
    Eur J Radiol; 2014 Jul; 83(7):1069-1073. PubMed ID: 24794862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal imaging of esophagus and cardia cancer before and after treatment.
    Fiore D; Baggio V; Ruol A; Bocus P; Casara D; Corti L; Muzzio PC
    Radiol Med; 2006 Sep; 111(6):804-17. PubMed ID: 16896560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.